Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

age was 600 mg/day), and is more common in the elderly.

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other comorbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated.

Hepatotoxicity, occasionally severe, may occur. Assess liver function before initiation of treatment and monthly thereafter or as clinically indicated. Monitor liver function when combined with chemotherapy known to be associated with liver dysfunction. A 25% decrease in the recommended dose should be used for patients with severe hepatic impairment.

Patients with moderate renal impairment (CrCL = 20-39 mL/min) should receive a 50% decrease in the recommended starting dose, and future doses can be increased as tolerated. Doses greater than 600 mg/day are not recommended in patients with mild renal impairment (CrCL = 40-59 mL/min). For patients with moderate renal impairment, doses greater than 400 mg/day are not recommended. Gleevec should be used with caution in patients with severe renal impairment.

In the newly diagnosed CML trial, 2% of patients had (NCI Grades 3/4) hemorrhage.

There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, acute respiratory failure, and gastrointestinal (GI) perforation.

Bullous dermatologic reactions (eg, erythema multiforme and Stevens-Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resol
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015 Research and Markets ( ... "Marine Biotechnology - Global Strategic Business Report" ... estimates and forecasts are provided for the period ... is provided for these markets. Market data and ... This report analyzes the worldwide markets ...
(Date:3/30/2015)... , March 30, 2015  Edelberg & Associates ... of its kind, real-time medical coding software platform ... physician, scribe and medical coder at the point ... initiative with ScribeAmerica, EA has successfully built, deployed ... real-time interaction between scribe and medical coder that ...
(Date:3/30/2015)... OF PRUSSIA, Pa. , March 30, 2015 ... the European Medicines Agency (EMA) has started the ... Application (MAA) for its long-acting fusion protein linking ... Upon European Commission approval, rIX-FP will provide hemophilia ... well as the European Economic Area (EEA) countries, ...
Breaking Medicine Technology:Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4
... Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort ... a non-binding letter of intent with BioTechnology Consulting Poland ... Candidate PulmoBind(TM) for development work, clinical trials and ultimately, ... pleased to have signed a non-binding LOI with BioTechnology ...
... H.R. 3790 Will Reduce Medicare Spending, Preserve Patient ... Businesses; Flawed Bid Process Begins on October 21 ... Orlando, Pittsburgh, and Riverside, Calif. , ARLINGTON, ... praised a bipartisan group of lawmakers in the House ...
Cached Medicine Technology:Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) 2Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) 3Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) 4American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment 2American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment 3American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment 4American Association for Homecare Backs Bipartisan Bill to Eliminate Medicare Bidding Program for Home Medical Equipment 5
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Foundations ... proud to announce the start of its 41st national ... author Jane McGonigal, and former Congressman Patrick J. Kennedy ... Conference being held in San Diego, CA, March ... Coronado. The national conference brings together leading experts specializing ...
(Date:3/30/2015)... March 30, 2015 With the summer ... stricken areas are scrambling to make sure they have ... individuals to be aware that when Earth loses water ... water and become dehydrated. Kleyne calls this “body drought” ... Kleyne talked about weather, body drought and dehydration on ...
(Date:3/30/2015)... 30, 2015 Health Fitness Revolution, founded by ... the World Samir Becic, has created a new list of ... which recognizes the world’s fittest leaders in terms of physical ... only list of its kind to detail the health and ... Among the world leaders profiled on the list are Israel’s ...
(Date:3/30/2015)... In its 2015 survey of construction and design ... among the top general contractors in healthcare construction, based ... healthcare construction for more than half of their 69 ... the list with $657 million in revenue for completed ... square feet with 82 percent of its work in ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 ... has compiled the most frequently asked questions to ... on the process of egg donation. , ... program in early February, the IVF clinic has ... Verda Tunçbilek, the reputable fertility center provides attentive reproductive ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 2Health News:As California Dry Season Approaches, Risk of Body Drought Increases, Warns Fresh Water Advocate 3Health News:The Top 13 Fittest Heads of State: Why Putin Might Be No. 1 in Health and Fitness 2Health News:Modern Healthcare Ranks Robins & Morton No. 6 Contractor 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4
... Reporter , TUESDAY, March 22 (HealthDay News) -- Use of ... rise in the United States despite research that suggests they ... Fibrates are often prescribed to people with low levels of ... harmful form of fat circulating in the blood, experts explained. ...
... To help continue its internationally recognized work in Lewy ... awarded Mayo Clinic a $1 million gift, pledged over four ... Alzheimer,s and Parkinson,s diseases , is the second ... VIDEO ALERT: Additional audio and video resources, including ...
... University has started recruiting patients for a new ... whether the cholesterol-reducing drug rosuvastatin is effective in ... laboratory research and population studies have shown that ... lowers cholesterol, had fewer colon polyps, which can ...
... Reporter , MONDAY, March 21 (HealthDay News) -- Affluent ... for tanning -- are nearly six times as likely ... poorest counterparts, a new study indicates. In research ... exposure and socioeconomic status, scientists studied data from 3,800 ...
... protein provides protection against the effects of alcohol in the ... the Medical Research Council, could lead to the development of ... cancer. The protein, calmodulin, is involved in the basic ... of the body. This study reveals that when calmodulin is ...
... UK coalition government,s planned NHS and welfare reforms, and their ... and recession from the end of the nineteenth century, according ... paper has recently been published in the Lancet . ... a nudge from history, is his second in the Lancet ...
Cached Medicine News:Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 2Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 3Health News:Study Questions Rise in Use of Certain Cholesterol Drugs 4Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 2Health News:Gift will allow Mayo researchers to explore cause of dementia in the elderly 3Health News:Jefferson clinical trial: Can a cholesterol drug prevent colon cancer? 2Health News:Richer White Women More Prone to Melanoma, Study Finds 2Health News:Richer White Women More Prone to Melanoma, Study Finds 3Health News:Protein could be used to treat alcohol effects on pancreas 2Health News:Report indicates that 'new' welfare reforms hark back to Victorians 2
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
Medicine Products: